File(s) under permanent embargo
Uptake of bone modifying agents in patients with HER2+ metastatic breast cancer with bone metastases – prospective data from a multi-site Australian registry
journal contribution
posted on 2021-05-18, 00:00 authored by Vanessa Wong, Richard Boer, Catherine Dunn, Angelyn Anton, Laeeq Malik, Sally Greenberg, Belinda Yeo, Louise Nott, Ian CollinsIan Collins, Javier Torres, Frances Barnett, Michelle Nottage, Peter Gibbs, Sheau Wen LokUptake of bone modifying agents in patients with HER2+ metastatic breast cancer with bone metastases – prospective data from a multi-site Australian registry
History
Journal
Internal medicine journalPagination
1 - 21Publisher
WileyLocation
Chichester, Eng.Publisher DOI
ISSN
1444-0903eISSN
1445-5994Language
engPublication classification
C1 Refereed article in a scholarly journalUsage metrics
Categories
No categories selectedKeywords
Science & TechnologyLife Sciences & BiomedicineMedicine, General & InternalGeneral & Internal Medicinebreast cancerbone-modifying agentsbone metastasesoncologybone healthSKELETAL-RELATED EVENTSZOLEDRONIC ACIDDENOSUMAB DISCONTINUATIONVERTEBRAL FRACTURESCOST-EFFECTIVENESSMULTIPLE-MYELOMADOUBLE-BLINDEARLY-STAGEEFFICACYSAFETY